ADVENTRX updates ANX-514 candidate for FDA approval ADVENTRX Pharmaceuticals, Inc. Today provided an revise on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel www.suomi-info.net .S. Meals and Drug Administration decided that ANX-514 cannot be approved based on the findings from the bioequivalence research of ANX-514 and that additional development activities would be required for acceptance. Culley, Chief Executive Officer of ADVENTRX. Culley continued. The pilot plan, named ACTIVATE Children, was created to educate children on the risks of childhood weight problems. The children can acquire privileges to perform on Wii Suit and Wii Resort, which prompts kids to use various types of exercise to complete games..